Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (81-90 of 490) with videos related to

Pageof 49
Sort By:
Hepatology (Baltimore, Md.)|July 14, 2022
Letter to the editor: Change in serial liver stiffness measurement by magnetic resonance elastography and outcomes in NAFLDGeorg Semmler, Katrine Holtz Thorhauge, Thomas Reiberger, et al.
Hepatology (Baltimore, Md.)|September 17, 2016
Liver Capsule: FXR agonists against liver diseaseClaudia D Fuchs, Philipp Schwabl, Thomas Reiberger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2023
Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertensionLaura Turco, Thomas Reiberger, Giovanni Vitale, et al.
JHEP Reports : Innovation in Hepatology|February 2, 2026
Extending the Baveno VII definition of recompensation to autoimmune hepatitis: Considerations regarding treatment timing and response criteriaBenedikt S Hofer, Lukas Burghart, Thomas Reiberger, et al.
Wiener Klinische Wochenschrift|June 11, 2026
Evolution of liver disease severity and portal hypertension during REP 2139-Mg treatment in 3 patients with chronic hepatitis D : Case reportsMathias Jachs, Michael Schwarz, Mattias Mandorfer, et al.
The Lancet. Gastroenterology & Hepatology|August 8, 2025
Recompensation in decompensated cirrhosisMadhumita Premkumar, Patrick S Kamath, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics|August 20, 2025
Editorial: Redefining Decompensation in Cirrhosis-More Than an Academic Playground? Authors' ReplyLucie Simonis, Lorenz Balcar, Georg Kramer, et al.
European Journal of Radiology|March 11, 2026
Reply to Letter to the Editor: Correlation between MRI-derived and biopsy-confirmed liver iron concentration in patients with chronic liver diseaseSami A Ba-Ssalamah, Michael Schwarz, Thomas Reiberger, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 29, 2017
Management of portal hypertension before and after liver transplantationLukas W Unger, Gabriela A Berlakovich, Michael Trauner, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 14, 2022
Reply to comment: Von Willebrand factor measurement during acute decompensationMattias Mandorfer, Katharina Pomej, Bernhard Scheiner, et al.
Pageof 49

Showing results (81-90 of 490) with videos related to

Sort By:
Pageof 49
Hepatology (Baltimore, Md.)|July 14, 2022
Letter to the editor: Change in serial liver stiffness measurement by magnetic resonance elastography and outcomes in NAFLDGeorg Semmler, Katrine Holtz Thorhauge, Thomas Reiberger, et al.
Hepatology (Baltimore, Md.)|September 17, 2016
Liver Capsule: FXR agonists against liver diseaseClaudia D Fuchs, Philipp Schwabl, Thomas Reiberger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2023
Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertensionLaura Turco, Thomas Reiberger, Giovanni Vitale, et al.
JHEP Reports : Innovation in Hepatology|February 2, 2026
Extending the Baveno VII definition of recompensation to autoimmune hepatitis: Considerations regarding treatment timing and response criteriaBenedikt S Hofer, Lukas Burghart, Thomas Reiberger, et al.
Wiener Klinische Wochenschrift|June 11, 2026
Evolution of liver disease severity and portal hypertension during REP 2139-Mg treatment in 3 patients with chronic hepatitis D : Case reportsMathias Jachs, Michael Schwarz, Mattias Mandorfer, et al.
The Lancet. Gastroenterology & Hepatology|August 8, 2025
Recompensation in decompensated cirrhosisMadhumita Premkumar, Patrick S Kamath, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics|August 20, 2025
Editorial: Redefining Decompensation in Cirrhosis-More Than an Academic Playground? Authors' ReplyLucie Simonis, Lorenz Balcar, Georg Kramer, et al.
European Journal of Radiology|March 11, 2026
Reply to Letter to the Editor: Correlation between MRI-derived and biopsy-confirmed liver iron concentration in patients with chronic liver diseaseSami A Ba-Ssalamah, Michael Schwarz, Thomas Reiberger, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 29, 2017
Management of portal hypertension before and after liver transplantationLukas W Unger, Gabriela A Berlakovich, Michael Trauner, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 14, 2022
Reply to comment: Von Willebrand factor measurement during acute decompensationMattias Mandorfer, Katharina Pomej, Bernhard Scheiner, et al.
Pageof 49